in left parietal lobe with low signal intensity on T1, high signal intensity on T2 and was hyper intense on FLAIR . There was no evidence of acute intra cranial bleeding. The lesion showed homogenous enhancement with contrast. Whole body Positron Emission Tomography-Computerized Tomographic fusion (PET-CT) scan did not show any significant uptake. He underwent left parieto-occipital craniotomy with complete removal of gross tumor. The pathology
A 48-year old male, initially presented to the local hospital with generalized tonic-clonic seizure episodes for almost eight months. He had no previous head trauma, family history or chronic illness. There was no focal neurological deficit. in left parietal lobe with low signal intensity on T1, high signal intensity on T2 and was hyper intense on FLAIR . There was no evidence of acute intra cranial bleeding. The lesion showed homogenous enhancement with contrast. Whole body Positron Emission Tomography-Computerized Tomographic fusion (PET-CT) scan did not show any significant uptake. He underwent left parieto-occipital craniotomy with complete removal of gross tumor. The pathology showed large cell lymphoma and immuno histochemistry revealed positive CD20 (diffuse and strong), CD79A, bcl-2, bcl-6, CD5, CD43, and MUM1 while CD3, CD10, CD23, and cyclin D1 was negative. Fluorescent in situ hybridization did not reveal any chromosomal abnormality, specifically no c-myc abnormality was found. Whole brain PET-scan post craniotomy did not show any residual disease.The final diagnosis was primary CNS of diffuse large B-cell type. He was started on chemotherapy consisting of high dose Methotrexate and cytosine arabinoside. After receiving two cycles of chemotherapy, he presented with newly developed skin nodules around the craniotomy scar associated with pruritis and erythema. CT scan of the brain with contrast showed large left
